Speaker 1: Hey everyone, welcome back to The Well-Built Life. I am
Speaker 1: Rachel Caldwell, alongside Thomas Bennett, and we are so glad
Speaker 1: you are tuning in. We are here to cut through
Speaker 1: the noise, skip the intense jargon and extreme rules, and
Speaker 1: share simple, practical habits that help you feel stronger, healthier,
Speaker 1: and more balanced every single day. Grab a drink, get comfortable,
Speaker 1: and let's dive in. So let's dive into the nitty
Speaker 1: gritty here. At the heart of hypothyroidism, Hashimoto's thyroiditis stands
Speaker 1: as the primary cause, especially in iodine-fortified countries. It's a
Speaker 1: silent assault on the thyroid gland driven by a self-destructive
Speaker 1: immune response.
Speaker 2: Absolutely. The immune system turns on the thyroid, producing antibodies
Speaker 2: that target and destroy thyroid cells. This makes the thyroid
Speaker 2: less effective, leading to a drop in the production of
Speaker 2: thyroid hormones, which are essential for metabolic balance.
Speaker 1: That's right. Key symptoms start to emerge when thyroid hormones
Speaker 1: fall too low, fatigue, weight gain, and feeling cold are common.
Speaker 1: But let's unpack the more serious end of the spectrum.
Speaker 1: Myxedema coma, for instance, is a life-threatening emergency.
Speaker 2: Precisely. It's a severe manifestation of hypothyroidism where patients may
Speaker 2: experience hypothermia, bradycardia, and lethargy. It's a critical alert that
Speaker 2: something's really wrong.
Speaker 1: Yes. And the treatment is multifaceted, supportive care, corticosteroids, replacement therapy,
Speaker 1: and addressing any underlying factors. But as we dig deeper,
Speaker 1: hashy toxicosis is another fascinating phenomenon.
Speaker 2: Exactly. It's like the thyroid storm in reverse. In this phase,
Speaker 2: Teresa burst of autoantibody production leading to hyperthyroid symptoms, tachycardia,
Speaker 2: heat intolerance, and weight loss. We need to catch it
Speaker 2: early to prevent serious complications. Right.
Speaker 1: And the diagnostic journey is crucial. A simple TSH and
Speaker 1: free T4 test can show us whether we are dealing
Speaker 1: with hypothyroidism or subclinical issues. High TSH and low free
Speaker 1: T4 are classic signs, but it's the presence of those
Speaker 1: specific antithyroid antibodies, TP-AB and TG-AB, that really pin the
Speaker 1: diagnosis on Hashimoto's.
Speaker 2: Not to mention the physical signs can be quite telling.
Speaker 2: A smooth, diffusely enlarged thyroid gland, delayed tendon reflexes, dry skin,
Speaker 2: and fragile hair. It's like the gland is taking its
Speaker 2: time to announce it's having a bad day.
Speaker 1: Yes, and the management strategy is tailored. For those with
Speaker 1: high TSH, we start with levothyroxine. It's a stepwise approach,
Speaker 1: adjusting doses based on TSH responses to keep the thyroid
Speaker 1: functioning at an optimal level.
Speaker 2: But we can't forget the context. Patients with Hashimoto's are
Speaker 2: at a slightly higher risk of adrenal insufficiency, so we'd
Speaker 2: want to check those basal cortisol levels before jumping into levothyroxine.
Speaker 1: Agreed, and then to raise the papillary thyroid carcinoma risk,
Speaker 1: which we need to monitor closely with any palpable nodules.
Speaker 2: It's a comprehensive conversation, but essential for our listeners to understand.
Speaker 2: Hashimoto's thyroiditis isn't just about the hormones. It's a system-wide
Speaker 2: interplay of immune, metabolic, and even psychological factors.
Speaker 1: So, let's dive into the mechanisms and diagnosis of Hashimoto's thyroiditis. First,
Speaker 1: let's talk about the role of autoantibodies in destroying thyroid cells.
Speaker 1: Can you break down how this actually works, Thomas?
Speaker 2: Absolutely, Rachel. In Hashimoto's, the immune system mistakenly attacks the
Speaker 2: thyroid gland. producing autoantibodies like antithyroid peroxidase, Apoend, antithyroglobulin, Taichi antibodies.
Speaker 2: These autoantibodies target crucial thyroid enzymes and proteins, disrupting the
Speaker 2: synthesis of thyroid hormones.
Speaker 1: Right, and that's the crucial nuance here. How exactly do
Speaker 1: these antibodies target specific enzymes and proteins in the thyroid cells?
Speaker 2: Essentially, the immune system recognizes thyroid, specific antigens as foreign,
Speaker 2: leading to an inflammatory response that damages the thyroid follicular cells.
Speaker 2: TPO antibodies bind to the thyroid peroxidase enzyme, interfering with
Speaker 2: the iodination of tyrosine residues, which is a key step
Speaker 2: in producing thyroid hormones like T3 and T4. Similarly, TG
Speaker 2: antibodies attack thyroglobulin, a protein that stores thyroid hormones, This
Speaker 2: destruction leads to a gradual decrease in thyroid hormone production.
Speaker 1: That's a vivid way to put it. So, how does
Speaker 1: the diagnosis of Hashimoto's thyroiditis typically play out in clinical practice?
Speaker 2: The diagnostic journey starts with blood tests. We look for
Speaker 2: the presence of TPO and TG antibodies, which are present
Speaker 2: in 95% and 60-80% of Hashimoto's patients, respectively. If these
Speaker 2: autoantibodies are found, The next step is to assess TSH
Speaker 2: and free T4 levels. A high TSH and low free
Speaker 2: T4 usually confirms primary hypothyroidism.
Speaker 1: And what about the initial clinical assessments? Once you suspect Hashimoto's,
Speaker 1: what immediate steps do you take?
Speaker 2: Right. It's a multi-step process. First, perform an ABDE assessment
Speaker 2: to check for any instability signs. If a patient presents
Speaker 2: with hypothermia, bradycardia, and lethargy, We suspect Myxedema Coma, a
Speaker 2: severe form of hypothyroidism. Treatment involves immediate intubation and mechanical
Speaker 2: ventilation if necessary, IV access, and continuous monitoring of vital signs.
Speaker 1: Interesting. And what about patients who seem to be in
Speaker 1: a hyperthyroid phase, experiencing symptoms like tachycardia and heat intolerance?
Speaker 1: How do we handle those cases differently?
Speaker 2: Ah, Hashitoxicosis. This is a transient phase in Hashimoto's where
Speaker 2: teres a burst of autoantibody activity, leading to a temporary
Speaker 2: hyperthyroid state. We manage these patients with antithyroid drugs to
Speaker 2: lower thyroid hormone levels and beta blockers to control heart rate.
Speaker 2: It's a delicate balance, but crucial to prevent potential cardiac complications.
Speaker 1: That's a comprehensive approach. So, as we wrap up this section...
Speaker 1: What are the key takeaways for our listeners?
Speaker 2: The main points are understand the role of autoantibodies in
Speaker 2: destroying thyroid cells, recognize the diagnostic criteria involving TPOAB and TJAB,
Speaker 2: and perform initial clinical assessments to determine severity. Monitoring and
Speaker 2: adjusting treatment based on TSH and free T4 levels are essential.
Speaker 2: And always, always check for any signs of adrenal insufficiency
Speaker 2: or risk of papillary thyroid carcinoma.
Speaker 1: Great, Thomas. That covers everything we need to know about
Speaker 1: the mechanisms and diagnosis of Hashimoto's. Next time, we will
Speaker 1: get into the treatment and management aspects. Stay tuned. So, Thomas,
Speaker 1: when we move into treatment, it's all about managing those
Speaker 1: TSH and free T4 levels effectively. Let's start with the basics.
Speaker 1: What's the deal with TSH and free T4?
Speaker 2: Great, Rachel. It's crucial to understand that these levels are
Speaker 2: like the master key and the front door to your thyroid.
Speaker 2: 2SH is basically the brain signal to the thyroid to
Speaker 2: produce hormones. When 2SH levels are high, it means the
Speaker 2: brain is shouting, make more hormones because the thyroid can't
Speaker 2: keep up. Free T4, on the other hand, is the
Speaker 2: actual hormone that does all the work once it gets
Speaker 2: to your cells. Right.
Speaker 1: And that's why it's important to align both of these
Speaker 1: levels to ensure the thyroid's output is just right. Now,
Speaker 1: let's walk through the step-by-step process of how we get there.
Speaker 1: Starting with TSH. What's the first thing clinicians should look for?
Speaker 2: The first step is to check if TSH is above
Speaker 2: 10 mL. If it's high, it's a pretty strong sign
Speaker 2: that levothyroxine is needed. We have got to start the
Speaker 2: treatment here because the high TSH is indicating that the
Speaker 2: thyroid isn't keeping up with the body's needs.
Speaker 1: Exactly. And once we start the treatment with levothyroxine, the
Speaker 1: next step is to monitor TSH levels within three to
Speaker 1: six weeks. This is like a tuning check. Up after
Speaker 1: adjusting the engine, how do we know if we need
Speaker 1: to boost the dose or if it's too much?
Speaker 2: Right. You will want to titrate based on the TSH response.
Speaker 2: If the TSH is still high, you may need to
Speaker 2: increase the dose. Conversely, if it drops too low, you
Speaker 2: might need to reduce the dose. The goal is to
Speaker 2: get that TSH to around the normal range, which is
Speaker 2: usually between 0.4 and 4.0 muon. But remember, we are
Speaker 2: not just looking at numbers, we are looking at outcomes.
Speaker 1: True, and here is where it gets interesting. Certain patient
Speaker 1: factors come into play. For instance, age plays a big
Speaker 1: role in patients under 65 to 70 we are more
Speaker 1: likely to initiate treatment sooner to hit that target TSH.
Speaker 1: Why is that?
Speaker 2: Well, Rachel, in younger patients, the thyroid's effects are more pronounced,
Speaker 2: and they may benefit more from hormone replacement to avoid
Speaker 2: long-term complications. That's key in terms of managing hypothyroidism effectively. Also,
Speaker 2: fertility is a big concern here. If we are dealing
Speaker 2: with a patient who wants to conceive... We know that
Speaker 2: treating hypothyroidism optimally can significantly impact pregnancy outcomes.
Speaker 1: Exactly. Not only do we need to focus on the
Speaker 1: TSH and free T4, but also on individual needs. For example,
Speaker 1: a 30-year woman hoping to get pregnant might benefit more
Speaker 1: from active treatment than someone in their 60s. This is
Speaker 1: because the effects of hypothyroidism on fertility are more immediate
Speaker 1: and severe in the younger group.
Speaker 2: Absolutely. It's like looking at a racehorse versus a mule.
Speaker 2: You are looking at the performance curve. The younger you are,
Speaker 2: the more responsive your body is to treatment. And it's
Speaker 2: not just about numbers. It's about the holistic impact on
Speaker 2: daily function and quality of life, especially when it comes
Speaker 2: to pregnancy planning.
Speaker 1: So, to wrap up this segment, the takeaway is that
Speaker 1: TSH and free T4 levels are intertwined, and the treatment
Speaker 1: process is a dynamic, personalized journey. Age and fertility are
Speaker 1: just two of the many factors that we need to consider.
Speaker 1: when managing hypothyroidism effectively. So how does the quality of
Speaker 1: life for someone with Hashimoto's thyroiditis actually play out day
Speaker 1: to day? I mean, we know there are physical symptoms
Speaker 1: like fatigue, weight gain, and hair loss. But is there
Speaker 1: more to it?
Speaker 2: Absolutely, Rachel. Beyond the obvious physical symptoms, Hashimoto's can have
Speaker 2: a profound impact on neurological and cognitive functions. Patients often
Speaker 2: report feeling foggy or having trouble focusing. memory problems are common,
Speaker 2: and anxiety and depression can become significant issues as well.
Speaker 1: Right, and that's the crucial nuance here. It's not just
Speaker 1: about the physical ailments, but how these conditions can really
Speaker 1: impact a person's daily functioning and mental state. Has there
Speaker 1: been any research on how these neurological symptoms play out
Speaker 1: over time?
Speaker 2: There have been several studies that show a direct link
Speaker 2: between hypothyroidism and neuropsychiatric symptoms. For instance, A study found
Speaker 2: that even mild thyroid dysfunction can lead to cognitive decline,
Speaker 2: especially affecting executive function and attention. It's like the thyroid
Speaker 2: is the conductor, and when it's not working well, the
Speaker 2: entire orchestra is off-tune.
Speaker 1: That's wild when you look at the raw numbers. But
Speaker 1: moving on, what about the increased risk of papillary thyroid
Speaker 1: carcinoma in patients with Hashimoto's? How does that factor into
Speaker 1: all of this?
Speaker 2: That's a good point, Rachel. The link between Hashimoto's and
Speaker 2: papillary thyroid carcinoma is well documented. Studies suggest that individuals
Speaker 2: with Hashimoto's have a 2 to 7 times higher risk
Speaker 2: of developing papillary thyroid carcinoma compared to the general population.
Speaker 2: It's not clear exactly why, but one theory is that
Speaker 2: the chronic inflammation and autoimmune process might be contributing to
Speaker 2: cellular changes that lead to cancer.
Speaker 1: Interesting. So, when a patient with Hashimoto's presents with a
Speaker 1: thyroid nodule, what's the first step? What should be done
Speaker 1: to investigate further?
Speaker 2: You'd take a methodical approach. First, you'd order an ultrasound
Speaker 2: to visualize the nodule and check for any suspicious features
Speaker 2: like irregular borders or calcifications. Then, you might consider doing
Speaker 2: a fine needle aspiration biopsy if the ultrasound findings are concerning.
Speaker 2: This helps rule out malignancy and guides treatment decisions.
Speaker 1: That makes sense. It's a balance between being proactive and
Speaker 1: avoiding unnecessary intervention. I guess this just underscores the importance
Speaker 1: of regular checkups and thyroid function monitoring, especially for those
Speaker 1: with a history of autoimmune disorders.
Speaker 2: Exactly. Regular monitoring is crucial because, as I mentioned, papillary
Speaker 2: thyroid carcinoma is more common in Hashimoto's patients. But it's
Speaker 2: not a death sentence. With early detection, the prognosis can
Speaker 2: be very good. The key is catching any changes early.
Speaker 1: Absolutely. It's all about the holistic approach to managing this condition. Thanks, Thomas,
Speaker 1: for breaking it down. I think our listeners now have
Speaker 1: a much better understanding of the broader impacts of Hashimoto's.
Speaker 2: My pleasure, Rachel. And remember, it's not just about the thyroid,
Speaker 2: it's about the whole person. That's why a multidisciplinary approach
Speaker 2: is so important in treating Hashimoto's thyroiditis. So?
Speaker 1: As we wrap up our discussion on Hashimoto's thyroiditis, let's
Speaker 1: talk about the future outlook and key takeaways. The landscape
Speaker 1: of research is ever-evolving, and staying ahead means staying informed. Thomas,
Speaker 1: what are some of the latest research trends we should
Speaker 1: pay attention to?
Speaker 2: Right, and that's the crucial nuance here, Rachel. One of
Speaker 2: the key areas is understanding genetic and environmental factors that
Speaker 2: could predispose someone to Hashimoto's, Recent studies are exploring the
Speaker 2: interplay between genetics and stress, which can trigger the autoimmune response. Also,
Speaker 2: Therese knew research indicating that gut health might play a
Speaker 2: significant role, with certain bacteria influencing the immune system.
Speaker 1: That's wild when you look at the raw numbers. And
Speaker 1: it makes sense, too. The gut plays a vital role
Speaker 1: in overall health, so it's not surprising to see it
Speaker 1: linked to autoimmune conditions. On the treatment front? What do
Speaker 1: you see as the next big advancement?
Speaker 2: Exactly another interesting direction. Current drug treatments are effective but
Speaker 2: not without side effects. Research is now focusing on using
Speaker 2: immunomodulatory therapies to dampen the immune response specifically against the thyroid.
Speaker 2: Some trials have shown promising results with agents like prednisone
Speaker 2: and leflinomide, which can potentially modulate the immune system to
Speaker 2: reduce inflammation and damage.
Speaker 1: That's exciting. And it's not just about treatments. Ongoing monitoring
Speaker 1: is crucial, isn't it? How should patients be approaching this?
Speaker 2: Absolutely. The idea is to be proactive rather than reactive.
Speaker 2: Patients should have regular checkups to monitor TSH levels and
Speaker 2: thyroid hormone levels. This helps in catching any subtle changes early.
Speaker 2: The risk for complications like myxedema coma is real, so
Speaker 2: prompt attention to symptoms is key. Agreed.
Speaker 1: And let's not forget that managing Hashimoto's is a multifaceted approach.
Speaker 1: It's not just about the medication, but also lifestyle changes.
Speaker 1: Do you have any strategies for long-term management that you recommend?
Speaker 2: Great question. For those dealing with Hashimoto's, a few actionable
Speaker 2: steps include maintaining a balanced diet, managing stress through mindfulness
Speaker 2: or other techniques, and getting regular exercise. These lifestyle factors
Speaker 2: can help stabilize hormone levels. and improve overall well-being.
Speaker 1: Exactly. It's all about that holistic approach, making sure that
Speaker 1: every aspect of health is taken care of. It's really
Speaker 1: about empowering the patient to take control of their health
Speaker 1: and prevent complications. What would you say to someone who's
Speaker 1: newly diagnosed and feeling overwhelmed?
Speaker 2: For them, I'd say focus on small, consistent changes. It's
Speaker 2: not about achieving perfection overnight, but making a plan and
Speaker 2: sticking to it. Educate yourself about the condition, work closely
Speaker 2: with your healthcare provider, and remember that you are not alone.
Speaker 2: Support groups and online communities can provide a wealth of
Speaker 2: information and emotional support.
Speaker 1: Absolutely. It's all about that journey and taking it one
Speaker 1: step at a time. Thanks, Thomas, for your insights. This
Speaker 1: has really given us a well-rounded view of the future
Speaker 1: outlook for Hashimoto's.
Speaker 2: My pleasure, Rachel. And remember... The journey towards managing Hashimoto's
Speaker 2: is a marathon, not a sprint. With the right tools
Speaker 2: and support, patients can lead healthy, fulfilling lives.
Speaker 1: That brings us to the end of today's episode. Thank
Speaker 1: you so much for spending part of your day with me.
Speaker 1: If you found this episode's tips helpful and want to
Speaker 1: make sure you don't miss the next conversation, please take
Speaker 1: a quick second to hit that subscribe or follow button
Speaker 1: on whatever platform you are listening on. It's a completely
Speaker 1: free way to support the show and helps more people
Speaker 1: find us. This podcast is independently produced, so if you
Speaker 1: are ever in a position where you would like to
Speaker 1: help keep it running, we do accept small donations. You
Speaker 1: can find a link right in the episode description below
Speaker 1: to buy us a coffee or contribute what you can.
Speaker 1: Every bit genuinely helps. Take care of yourself, stay balanced,
Speaker 1: and we will talk again soon.